Form 4 for CYTK CYTOKINETICS INC
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0001127602-23-003984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-08 | 2023-02-06 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $6.72 | +7,000 | 19.5K | +56% | +$47.0K |
| D | 2023-02-08 | 2023-02-06 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $45.00 | -7,000 | 12.5K | -36% | -$315.0K |
| D | 2023-02-08 | 2023-02-06 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $0.00 | -7,000 | 6,020 | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-06 | M | A | 7,000 | $6.72 | 19,533 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-06 | S | D | 7,000 | $45.00 | 12,533 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2023-02-06 | M | D | 7,000 | $0.00 | 6,020 | D | $6.72 · 2014-02-02 to 2024-01-02 | 7,000 Common Stock |